Recombinant Human APH1A Full Length Transmembrane protein (1-247 aa), His-SUMO-tagged
Cat.No. : | APH1A-2712H |
Product Overview : | Recombinant Human APH1A Protein (1-247 aa) is produced by in vitro E. coli expression system. This protein is fused with a 6xHis-SUMO tag at the N-terminal. Protein Description: Partial. |
- Specification
- Gene Information
- Related Products
- Download
Source : | In vitro E. coli expression system |
Species : | Human |
Tag : | His-SUMO |
Form : | If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0. |
Molecular Mass : | 42.9kDa |
Protein Length : | 1-247aa |
AA Sequence : | MGAAVFFGCTFVAFGPAFALFLITV AGDPLRVIILVAGAFFWLVSLLLAS VVWFILVHVTDRSDARLQYGLLIFG AAVSVLLQEVFRFAYYKLLKKADEG LASLSEDGRSPISIRQMAYVSGLSF GIISGVFSVINILADALGPGVVGIH GDSPYYFLTSAFLTAAIILLHTFWG VVFFDACERRRYWALGLVVGSHLLT SGLTFLNPWYEASLLPIYAVTVSMG LWAFITAGGSLRSIQRSLLCKD |
Purity : | Greater than 90% as determined by SDS-PAGE. |
Storage : | Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles. |
Reconstitution : | Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. |
Gene Name : | APH1A anterior pharynx defective 1 homolog A (C. elegans) [ Homo sapiens ] |
Official Symbol : | APH1A |
Synonyms : | APH1A; anterior pharynx defective 1 homolog A (C. elegans); gamma-secretase subunit APH-1A; APH 1A; CGI 78; aph-1alpha; presenilin-stabilization factor; APH-1; APH-1A; CGI-78; 6530402N02Rik; |
Gene ID : | 51107 |
mRNA Refseq : | NM_001077628 |
Protein Refseq : | NP_001071096 |
MIM : | 607629 |
UniProt ID : | Q96BI3 |
Products Types
◆ Recombinant Protein | ||
APH1A-184R | Recombinant Rhesus Macaque APH1A Protein, His (Fc)-Avi-tagged | +Inquiry |
APH1A-355R | Recombinant Rhesus monkey APH1A Protein, His-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (20)
Ask a questionAPH1A is related to Alzheimer's disease and other diseases, and has certain research and application prospects for the treatment of related diseases.
APH1A s are involved in the formation of gamma secretase complexes that regulate cell signaling pathways.
APH1A s interact with other gamma-secretase complex members, such as PS1 and Nct, to jointly regulate signaling in cells.
APH1A s, together with the gamma secretase complex, are involved in the production and metabolism of amyloid beta.
At present, the structural analysis of APH1A is relatively limited, but future studies may have important breakthroughs.
APH1A s are involved in the assembly of the gamma secretase complex, interacting with other members such as PS1 and Nct to achieve complex formation.
Studying the APH1A could help to understand how dysfunction of the gamma secretase complex contributes to the development of Alzheimer's disease.
The dysfunction of APH1A and γ-secretase complex is closely related to Alzheimer's disease.
The APH1A is a single membrane protein with a transmembrane structure.
The feasibility of functional loss repair depends on the specific degree and mechanism of loss, and the research is still in progress.
Yes, low APH1A expression is associated with some neurodegenerative diseases such as Alzheimer's disease.
APH1A can be synthesized by genetic engineering and purified by mass spectrometry, column chromatography and other techniques.
Antibodies to APH1A can be used to detect APH1A expression levels, which is helpful in the diagnosis of some neurodegenerative diseases.
APH1A participates in the function of γ-secreting enzyme complex, regulates the metabolism of amyloid beta, and is associated with memory function to some extent.
There are several subtypes of APH1A s, including APH1A-1 and APH1A-2.
APH1A s can be used to treat diseases associated with gamma secretase complexes, such as Alzheimer's disease.
Knockout models of APH1A s can be used to validate the role of APH1A in physiological and pathological processes and deepen our understanding of its function.
Yes, mutations in the APH1A may lead to dysfunction of the gamma secretase complex, leading to the development of related diseases.
APH1A plays an important role in regulating protein complex assembly and signaling in nervous system development.
Side effects of APH1A s include possible adverse reactions during treatment and other physiological changes associated with the gamma-secretase complex.
Customer Reviews (3)
Write a reviewAPH1A they produced were structurally stable and not prone to mutation.
The production process of APH1A is truly green and environmentally friendly, without any negative impact on the environment, and meets the requirements of environmental protection regulations.
This advantage of short half-life and high clearance allows APH1A to still act quickly in medical emergencies.
Ask a Question for All APH1A Products
Required fields are marked with *
My Review for All APH1A Products
Required fields are marked with *
Inquiry Basket